<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta name="viewport" content="width=device-width, initial-scale=1.0"/>
<title>503A vs. 503B Compounding Pharmacies: What Patients Need to Know | Ondra Health</title>
<meta name="description" content="What's the difference between a 503A and 503B compounding pharmacy? This plain-language guide explains both, what each means for your GLP-1 medication quality, and how Ondra's pharmacy partners fit in."/>
<script type="application/ld+json">
{ "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is a 503A compounding pharmacy?", "acceptedAnswer": { "@type": "Answer", "text": "A 503A compounding pharmacy is a state-licensed pharmacy that prepares custom medications based on individual patient prescriptions. They are regulated by state pharmacy boards, follow USP 797 sterile compounding standards for injectables, and compound medications one prescription at a time for individual patients." } }, { "@type": "Question", "name": "What is a 503B compounding pharmacy?", "acceptedAnswer": { "@type": "Answer", "text": "A 503B outsourcing facility is a large-scale compounding operation registered directly with the FDA. They can produce medications in bulk without individual prescriptions, must comply with Current Good Manufacturing Practices (cGMP), and are subject to regular FDA facility inspections. They can ship across state lines." } }, { "@type": "Question", "name": "Are compounded GLP-1 medications FDA-approved?", "acceptedAnswer": { "@type": "Answer", "text": "No. Compounded medications from both 503A and 503B pharmacies are not FDA-approved. The distinction between 503A and 503B is about facility oversight and scale of production, not FDA approval of the medication itself. Only brand-name Wegovy and Zepbound are FDA-approved." } }, { "@type": "Question", "name": "Can 503A pharmacies still compound semaglutide and tirzepatide?", "acceptedAnswer": { "@type": "Answer", "text": "503A state-licensed pharmacies can still legally compound semaglutide and tirzepatide for individual patients when there is a clinically documented need that the commercially available product cannot meet — such as a specific dose, formulation, or additive combination that differs meaningfully from the branded product. This is the pathway through which Ondra's licensed pharmacy partners continue to operate." } }, { "@type": "Question", "name": "How do I know if a compounding pharmacy is legitimate?", "acceptedAnswer": { "@type": "Answer", "text": "Look for: state pharmacy board licensure in your state, LegitScript certification (an independent verification program), compliance with USP 797 sterile compounding standards for injectables, a requirement for a valid prescription from a licensed provider, and a verifiable U.S. physical address and phone number." } }
] }
</script>
</head>
<body>
<section class="ondra-article-page"> <div class="ondra-article-hero"> <div class="ondra-article-container"> <div class="ondra-article-meta-row"> <span class="ondra-meta-pill">⏱ 6 min read</span> <span class="ondra-meta-pill">🏷 Medication Guides</span> </div> <h1 class="ondra-article-title">503A vs. 503B Compounding Pharmacies: What Patients Need to Know</h1> <p class="ondra-article-intro">If you're taking compounded semaglutide or tirzepatide, you've likely seen "503A" or "503B" on your prescription label — or heard these terms from your telehealth provider. Most patients have no idea what they mean. This plain-language guide explains both categories, how they differ in oversight and safety standards, and what they mean for the medication you're receiving.</p> </div> </div> <div class="ondra-article-container ondra-article-body"> <div class="ondra-article-layout" id="ondraArticleLayout"> <div class="ondra-article-main" id="ondraArticleMain"> <a href="/blog" class="ondra-back-link">← Back to all articles</a> <div class="ondra-takeaways-card"> <h2 class="ondra-card-heading">Key takeaways</h2> <div class="ondra-takeaway-item"><span class="ondra-check">✔</span><p><strong>503A pharmacies</strong> are state-licensed, patient-specific compounders — regulated by state pharmacy boards, require individual prescriptions.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check">✔</span><p><strong>503B facilities</strong> are federally registered, large-scale compounders — subject to FDA inspections and cGMP standards, can produce in bulk.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check">✔</span><p><strong>Neither produces FDA-approved drugs</strong> — both operate within defined legal frameworks for compounding.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check">✔</span><p>After the GLP-1 shortage ended in 2025, standard <strong>503B bulk compounding of semaglutide and tirzepatide ended</strong>. The 503A pathway for patient-specific prescriptions remains.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check">✔</span><p>When evaluating any pharmacy, verify <strong>state licensure, LegitScript status, and that a valid prescription is required</strong>.</p></div> </div> <div class="ondra-section"> <h2>What is a compounding pharmacy?</h2> <p>A compounding pharmacy creates custom medications for individual patients rather than mass-producing standardized drugs. Think of it as the difference between a bakery that makes each item to order versus a factory producing millions of identical units.</p> <p>Compounding has existed for centuries — it was the primary way medications were made before industrial pharmaceutical manufacturing. Today, it serves patients who need doses, formulations, or ingredient combinations that aren't available in commercially manufactured drugs.</p> <p>For GLP-1 medications, compounding allowed patients to access semaglutide and tirzepatide at a fraction of the cost of brand-name Wegovy ($1,349/month) or Zepbound, prescribed and dispensed through licensed telehealth providers like Ondra.</p> <p>Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), compounding pharmacies are divided into two distinct categories with very different regulatory frameworks.</p> </div> <div class="ondra-section"> <h2>503A — Traditional patient-specific compounding pharmacies</h2> <div class="ondra-info-card"> <p class="ondra-info-title">What 503A means</p> <p>503A pharmacies are state-licensed compounding pharmacies that prepare medications based on individual patient prescriptions. They are the traditional model of compounding — one prescription, one patient, compounded to order.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">Key characteristics</p> <p>Regulated by state pharmacy boards (not directly by the FDA). Must follow USP 797 sterile compounding standards for injectable medications. Compound medications based on a valid, patient-specific prescription from a licensed provider. Cannot produce medications in bulk without a prescription. Cannot ship across state lines unless licensed in those states. Typically smaller scale than 503B facilities.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">The analogy</p> <p>A 503A pharmacy is like a specialty bakery that makes custom cakes to order. Each one is made specifically for the person who ordered it, following a recipe provided by a licensed professional. Quality depends on the skill and standards of the individual bakery — and state pharmacy boards are the regulators enforcing those standards.</p> </div> </div> <div class="ondra-section"> <h2>503B — FDA-registered outsourcing facilities</h2> <div class="ondra-info-card"> <p class="ondra-info-title">What 503B means</p> <p>503B outsourcing facilities are large-scale compounding operations registered directly with the FDA. Unlike 503A pharmacies, they can produce medications in bulk — without individual prescriptions — for distribution to medical offices and healthcare facilities.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">Key characteristics</p> <p>Registered with and inspected by the FDA. Must comply with federal Current Good Manufacturing Practices (cGMP) — the same standards applied to pharmaceutical manufacturers. Can produce large batches without individual prescriptions. Subject to regular FDA facility inspections. Can ship across state lines. Higher production scale than 503A pharmacies.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">The analogy</p> <p>A 503B facility is like a food manufacturing plant. Both the local bakery and the plant produce food — but the plant has federal inspectors, standardized processes, and mandatory batch testing that the bakery is not required to have. More federal oversight doesn't mean the product is FDA-approved, but it does mean the facility is held to stricter production standards.</p> </div> </div> <div class="ondra-section"> <h2>Side-by-side comparison</h2> <div class="ondra-compare-table" role="table" aria-label="503A vs 503B compounding pharmacy comparison"> <div class="ondra-compare-row ondra-compare-header" role="row"> <div role="columnheader">Factor</div> <div role="columnheader">503A Pharmacy</div> <div role="columnheader">503B Facility</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Regulated by</div> <div role="cell" data-label="503A">State pharmacy board</div> <div role="cell" data-label="503B">FDA (federal)</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Prescription required</div> <div role="cell" data-label="503A">Yes — individual Rx required</div> <div role="cell" data-label="503B">No — can produce in bulk</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Scale</div> <div role="cell" data-label="503A">Smaller, patient-specific</div> <div role="cell" data-label="503B">Large-scale, bulk production</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">FDA facility inspections</div> <div role="cell" data-label="503A">No (state inspected)</div> <div role="cell" data-label="503B">Yes — regular FDA inspections</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">cGMP compliance required</div> <div role="cell" data-label="503A">No</div> <div role="cell" data-label="503B">Yes</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Cross-state shipping</div> <div role="cell" data-label="503A">Restricted to licensed states</div> <div role="cell" data-label="503B">Permitted</div> </div> <div class="ondra-compare-row" role="row"> <div class="ondra-feature-cell" role="cell">Products are FDA-approved</div> <div role="cell" data-label="503A">No</div> <div role="cell" data-label="503B">No</div> </div> </div> <p class="ondra-table-note">Neither 503A nor 503B compounded medications are FDA-approved drugs. The distinction is in facility oversight and production scale — not approval of the medication itself.</p> </div> <div class="ondra-section"> <h2>What changed after the GLP-1 shortage ended</h2> <p>During the semaglutide and tirzepatide shortage period (2022–2025), both 503A and 503B pharmacies were legally permitted to compound these medications under FDA shortage rules — giving millions of patients affordable access to GLP-1 therapy.</p> <p>The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025. This significantly changed the legal landscape:</p> <div class="ondra-info-card"> <p class="ondra-info-title">503B facilities (large-scale)</p> <p>Standard bulk compounding of semaglutide and tirzepatide by 503B outsourcing facilities ended as of May 2025. In April 2026, the FDA proposed permanently removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list — which, if finalized, would close this pathway permanently. Public comment closed June 2026 and a final determination is pending.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">503A pharmacies (patient-specific)</p> <p>State-licensed 503A pharmacies can still legally compound semaglutide and tirzepatide for individual patients when there is a clinically documented need that the commercially available product cannot meet — such as a specific dose, formulation, or additive combination (like the addition of B12 or glycine) that differs meaningfully from the branded product. This is the pathway through which Ondra's licensed pharmacy partners continue to operate.</p> </div> </div> <div class="ondra-section"> <h2>How to evaluate a compounding pharmacy</h2> <div class="ondra-info-card"> <p class="ondra-info-title">✔ State licensure</p> <p>The pharmacy should be licensed in your state. Verify through your state's pharmacy board — most have online license lookup tools.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">✔ LegitScript certification</p> <p>LegitScript is an independent verification program that confirms a pharmacy is operating legally and following applicable standards. The LegitScript seal is a meaningful quality signal. Ondra Health is LegitScript certified.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">✔ USP 797 sterile compounding compliance</p> <p>For injectable medications like semaglutide and tirzepatide, the pharmacy must follow USP 797 standards for sterile compounding. Ask your provider if you're unsure whether your pharmacy is compliant.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">✔ Prescription required</p> <p>A legitimate compounding pharmacy requires a valid prescription from a licensed provider before dispensing. Any pharmacy offering GLP-1 medications without a prescription is operating illegally.</p> </div> <div class="ondra-info-card"> <p class="ondra-info-title">✔ Verifiable U.S. address and phone number</p> <p>Legitimate pharmacies have a verifiable physical U.S. address and a working phone number. Be cautious of online-only operations with no physical location or only email/web contact forms.</p> </div> </div> <div class="ondra-section"> <h2>Ondra's pharmacy partners</h2> <p>Ondra works with licensed U.S. 503A compounding pharmacies operating under state pharmacy board oversight and complying with USP 797 sterile compounding standards. All prescriptions are written by licensed healthcare providers following clinical assessment of each patient.</p> <p>Current pharmacy partners include <strong>Hallandale Pharmacy, Boudreaux New Drug Store, Vials RX, Strive Pharmacy, BPI Labs, and Apothecary Pharma</strong> — all operating within applicable regulatory frameworks. Your specific pharmacy assignment is based on your state of residence, the medication prescribed, and current availability.</p> </div> <div class="ondra-section"> <h2>Frequently asked questions</h2> <div class="ondra-faq-item"> <h3>What is a 503A compounding pharmacy?</h3> <p>A 503A compounding pharmacy is a state-licensed pharmacy that prepares custom medications based on individual patient prescriptions. Regulated by state pharmacy boards, they compound medications one prescription at a time and must follow USP 797 standards for sterile injectable medications.</p> </div> <div class="ondra-faq-item"> <h3>What is a 503B compounding pharmacy?</h3> <p>A 503B outsourcing facility is a large-scale compounding operation registered directly with the FDA. They can produce medications in bulk without individual prescriptions, must comply with federal cGMP standards, and are subject to regular FDA facility inspections.</p> </div> <div class="ondra-faq-item"> <h3>Are compounded GLP-1 medications FDA-approved?</h3> <p>No. Compounded medications from both 503A and 503B pharmacies are not FDA-approved. The distinction between the two is about facility oversight and production scale — not FDA approval of the medication itself. Only brand-name Wegovy and Zepbound are FDA-approved.</p> </div> <div class="ondra-faq-item"> <h3>Can 503A pharmacies still compound semaglutide and tirzepatide?</h3> <p>Yes. State-licensed 503A pharmacies can still legally compound semaglutide and tirzepatide for individual patients when there is a clinically documented need the commercial product cannot meet — such as a specific formulation, dose, or additive combination. This is the pathway through which Ondra's licensed pharmacy partners operate.</p> </div> <div class="ondra-faq-item"> <h3>How do I know if a compounding pharmacy is legitimate?</h3> <p>Look for: state pharmacy board licensure in your state, LegitScript certification, USP 797 sterile compounding compliance for injectables, a requirement for a valid prescription from a licensed provider, and a verifiable U.S. physical address and phone number.</p> </div> </div> <p class="ondra-disclaimer">† This article is for educational purposes only and reflects the regulatory landscape as understood at time of publication. Compounding regulations are subject to change — the FDA's April 2026 proposal regarding the 503B bulks list is pending final determination. Always consult your licensed healthcare provider for guidance specific to your treatment. Compounded medications available through Ondra Health are not FDA-approved.</p> </div> <aside class="ondra-article-sidebar" id="ondraSidebarCol"> <div class="ondra-sidebar-track" id="ondraSidebarTrack"> <div class="ondra-sidebar-card-wrap" id="ondraSidebarWrap"> <div class="ondra-sidebar-card" id="ondraSidebarCard"> <div class="ondra-sidebar-top"> <p class="ondra-sidebar-eyebrow">ONDRA HEALTH</p> <h3>Provider-reviewed GLP-1 treatment from $113/mo</h3> </div> <div class="ondra-sidebar-bottom"> <div class="ondra-sidebar-item"><span>✔</span><p>Board-certified physician intake review</p></div> <div class="ondra-sidebar-item"><span>✔</span><p>Semaglutide & tirzepatide available</p></div> <div class="ondra-sidebar-item"><span>✔</span><p>Free shipping, flat pricing every dose</p></div> <div class="ondra-sidebar-item"><span></p></div> <a href="https://intake.ondra.health/start-online-visit/glp1" class="ondra-sidebar-button" target="_blank" rel="noopener noreferrer">Start your intake <span aria-hidden="true">→</span></a> <p class="ondra-sidebar-note">Only charged if a provider approves your treatment.</p> </div> </div> </div> </div> </aside> </div> </div>
</section>
</body>
</html>